PSCH
Invesco S&P SmallCap Health Care ETF
Invesco S&P SmallCap Health Care Portfolio is an exchange traded fund incorporated in the USA. The Fund's objective is to seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of the S&P SmallCap 600 Capped Health Care Index.
US
EQUITY
Passive
MANAGEMENT STYLE
181.0 M
ASSETS UNDER MGMT
29 bp
EXPENSES
Fund Basics
| Fund sponsor | Invesco |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | Apr 07, 2010 |
| Assets (mns) | $181 |
| Expense ratio | 29 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Quarterly |
| Taxation | 1099 |
| Stock selection | Committee |
| Weighting | Market Cap |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| GLAUKOS CORP | 4.8 % |
| MERIT MEDICAL SYSTEMS INC | 3.8 % |
| HIMS & HERS HEALTH, INC. CLASS A | 3.6 % |
| INSPIRE MEDICAL SYSTEMS, INC. | 3.5 % |
| CORCEPT THERAPEUTICS INC | 3.3 % |
| RADNET INC | 3.2 % |
| ALKERMES PLC | 3.2 % |
| QUIDELORTHO CORP | 3.1 % |
| INTEGER HOLDINGS CORPORATION | 2.9 % |
| ADMA BIOLOGICS, INC. | 2.7 % |
Constituent Breakdown
| Number of holdings | 70 |
| Herfindahl-Hirschman Index | 214 |
| Wgt avg mkt cap (mns) | $3,398 |
| Large cap (>$10bn) | 0.0% |
| Mid cap ($2-10bn) | 76.9% |
| Small cap (<$2bn) | 23.1% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Country Exposure
 |
UNITED STATES | 93.7 % |
 |
IRELAND | 3.2 % |
Historical Performance
Standardized Performance (as of 11/30/2024)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | Incep. | |
|---|---|---|---|---|---|---|---|
| Total Returns | 12.5% | 29.2% | -41.5% | -34.6% | -18.0% | -1.9% | 4.8% | Volatility | 19.4% | 21.2% | 20.5% | 23.4% | 26.5% | 23.3% | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.77 | 10% |
| MSCI EAFE | 0.66 | 7% |
| MSCI Emg Mkts | 0.07 | 0% |
Liquidity Measures
| Avg. volume (000) | 9 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.20% |
| ADV of underlying (mns) | $2,158 |
Technical Indicators
| Recent close | $44.80 |
| 30d moving avg. | $46.76 |
| Annualized volatility | 44.1% |
| Relative strength (RSI) | 44 |
| Short interest (ETF) | 0.3% |
| Short interest (underlying) | 6.7% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. PSCH |
Expenses vs. PSCH |
ALTAR Score™ vs. PSCH |
|---|---|---|---|---|
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 25.0% | +30 bp | -0.2% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 23.4% | +31 bp | -6.7% |
| XHS | SPDR S&P Health Care Services ETF | 22.6% | +6 bp | +2.4% |
| XHE | SPDR S&P Health Care Equipment ETF | 21.8% | +6 bp | -2.3% |
| SAWS | AAM Sawgrass US Small Cap Quality Growth ETF | 18.3% | +26 bp | +0.5% |
| XPH | SPDR S&P Pharmaceuticals ETF | 15.2% | +6 bp | +1.6% |
| SSLY | Syntax Stratified SmallCap ETF | 14.8% | +11 bp | +2.6% |
| SBIO | ALPS Medical Breakthroughs ETF | 14.4% | +21 bp | -6.1% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 13.9% | -11 bp | +1.9% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 13.7% | +1 bp | +2.8% |
Risk and Returns: PSCH vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| 2023 | 2024E | Fwd Est | 2025E | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 12/18/2024
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
PSCH
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
UNDERWEIGHT
Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.
ALTAR Score™
PSCH
4.2%
Cat. Avg
5.7%
ALTAR Score™ Calculation
Category Overview
There are 977 funds in the US Equity category, with an average ALTAR Score™
of 5.7% and a standard deviation of
2.6%. PSCH's ALTAR Score™ is approximately
0.6 standard deviations
below
the category average. This places PSCH in the 29th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
PSCHSELL
U/W
HOLD
O/W
BUY
Expense Analysis
| Peer Group | Passive US Equity ETFs |
| # of ETFs | 192 |
| Avg. Expense Ratio | 31.0 bp |
| Std. Deviation | 25.7 bp |
| PSCH (29 bp) Percentile rank | 46 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
| Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
|---|---|---|---|
| PSCH | 29.0 | 20.4 | 49.4 |
| Peer Avg. | 26.7 | 10.6 | 37.3 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .